Machine-designed biotherapeutics: opportunities, feasibility and advantages of deep learning in computational antibody discovery
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Antibodies are versatile molecular binders with an established and growing role as therapeutics. Computational approaches to developing and designing these molecules are being increasingly used to complement traditional lab-based processes. Nowadays, in silico methods fill multiple elements of the discovery stage, such as characterizing antibody–antigen interactions and identifying developability liabilities. Recently, computational methods tackling such problems have begun to follow machine learning paradigms, in many cases deep learning specifically. This paradigm shift offers improvements in established areas such as structure or binding prediction and opens up new possibilities such as language-based modeling of antibody repertoires or machine-learning-based generation of novel sequences. In this review, we critically examine the recent developments in (deep) machine learning approaches to therapeutic antibody design with implications for fully computational antibody design.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hochreiter, S., & Schmidhuber, J. (1997) · Neural Computation · doi:10.1162/neco.1997.9.8.1735 · Cited by 102,318
Highly accurate protein structure prediction with AlphaFold
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764
Varadi, M., Anyango, S., Deshpande, M., Nair, S., Natassia, C., Yordanova, G., Yuan, D., Stroe, O., Wood, G., Laydon, A., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkab1061 · Cited by 7,850
WaveNet: a generative model for raw audio
Oord, A. V. D., Dieleman, S., Zen, H., Simonyan, K., Vinyals, O., Graves, A., Kalchbrenner, N., Senior, A., & Kavukcuoglu, K. (2016) · arXiv · doi:10.48550/arxiv.1609.03499 · Cited by 4,911
Rives, A., Meier, J., Sercu, T., Goyal, S., Lin, Z., Liu, J., Guo, D., Ott, M., Zitnick, C. L., Ma, J., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2016239118 · Cited by 3,286
Rives, A., Meier, J., Sercu, T., Goyal, S., Lin, Z., Liu, J., Guo, D., Ott, M., Zitnick, C. L., Ma, J., et al. (2019) · doi:10.1101/622803 · Cited by 3,280 · cited 1×
“scale modeling 1b (ESM-1b) [114] performs worse than AbLang and copying germlines.”
MethodPatchDock and SymmDock: servers for rigid and symmetric docking
Schneidman-Duhovny, D., Inbar, Y., Nussinov, R., & Wolfson, H. J. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki481 · Cited by 3,018 · cited 1×
“They generated 5000 backbones and performed docking using PatchDock [127].”
MethodZDOCK: An initial‐stage protein‐docking algorithm
Chen, R., Li, L., & Weng, Z. (2003) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.10389 · Cited by 1,393 · cited 1×
“Docking was employed recently by deep learning for antibodies (DLAB) to address virtual screening by rescoring ZDOCK [96] poses in an antibody-specific fashion.”
MethodProtein 3D Structure Computed from Evolutionary Sequence Variation
Marks, D. S., Colwell, L. J., Sheridan, R., Hopf, T. A., Pagnani, A., Zecchina, R., & Sander, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028766 · Cited by 1,144 · cited 2×
“The latter were the hallmark of many previous methods in general protein structure prediction [10, 64, 70].”
BackgroundMethodReliable B cell epitope predictions: impacts of method development and improved benchmarking
Kringelum, J. V., Lundegaard, C., Lund, O., & Nielsen, M. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002829 · Cited by 697 · cited 1×
“Their method performs better than previous methods, namely EpiPred [80] and Discotope [82].”
MethodSAbDab: the structural antibody database
Dunbar, J., Krawczyk, K., Leem, J., Baker, T., Fuchs, A., Georges, G., Shi, J., & Deane, C. M. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1043 · Cited by 674
Self-citationBiophysical properties of the clinical-stage antibody landscape
Jain, T., Sun, T., Durand, S., Hall, A., Houston, N. R., Nett, J. H., Sharkey, B., Bobrowicz, B., Caffry, I., Yu, Y., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616408114 · Cited by 629 · cited 1×
“An antibody binder towards a therapeutic target should meet a range of biophysical features, termed collectively as manufacturability/developability [97].”
BackgroundCommonality despite exceptional diversity in the baseline human antibody repertoire
Briney, B., Inderbitzin, A., Joyce, C., & Burton, D. R. (2019) · Nature · doi:10.1038/s41586-019-0879-y · Cited by 544
Critical assessment of methods of protein structure prediction (CASP)—Round XIV
Kryshtafovych, A., Schwede, T., Topf, M., Fidelis, K., & Moult, J. (2021) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.26237 · Cited by 503
The CamSol method of rational design of protein mutants with enhanced solubility
Sormanni, P., Aprile, F. A., & Vendruscolo, M. (2015) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.09.026 · Cited by 494 · cited 1×
“The authors calculated the Fvcsp [87], Camsol score [88] and NetMHC2PAN [89] to filter the set of predicted binders.”
MethodFive computational developability guidelines for therapeutic antibody profiling
Raybould, M. I. J., Marks, C., Krawczyk, K., Taddese, B., Nowak, J., Lewis, A. P., Bujotzek, A., Shi, J., & Deane, C. M. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1810576116 · Cited by 357 · cited 2×
“models [59] or non-deep learning approaches such as random forests [98] that were reviewed in-depth elsewhere [99].”
BackgroundMethodSelf-citationImpact of Product-Related Factors on Immunogenicity of Biotherapeutics
Singh, S. K. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22276 · Cited by 350
Computational design of antibody-affinity improvement beyond in vivo maturation
Lippow, S. M., Wittrup, K. D., & Tidor, B. (2007) · Nature Biotechnology · doi:10.1038/nbt1336 · Cited by 342 · cited 1×
“One of the seminal works on computational antibody design was the framework of Lippow in 2007 [118].”
BackgroundBenchmarking AlphaFold for protein complex modeling reveals accuracy determinants
Yin, R., Feng, B. Y., Varshney, A., & Pierce, B. G. (2021) · doi:10.1101/2021.10.23.465575 · Cited by 335
Benchmarking AlphaFold for protein complex modeling reveals accuracy determinants
Yin, R., Feng, B. Y., Varshney, A., & Pierce, B. G. (2022) · Protein Science · doi:10.1002/pro.4379 · Cited by 335
Protein design and variant prediction using autoregressive generative models
Shin, J.-E., Riesselman, A. J., Kollasch, A. W., McMahon, C., Simon, E., Sander, C., Manglik, A., Kruse, A. C., & Marks, D. S. (2021) · Nature Communications · doi:10.1038/s41467-021-22732-w · Cited by 320 · cited 3×
“input neuron 68 will correspond to international ImMunoGeneTics information system (IMGT) position 56) but can also be approached by learning alignment-free dependencies [17].”
BackgroundMason, D. M., Friedensohn, S., Weber, C. R., Jordi, C., Wagner, B., Meng, S. M., Ehling, R. A., Bonati, L., Dahinden, J., Gainza, P., et al. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00699-9 · Cited by 308
High frequency of shared clonotypes in human B cell receptor repertoires
Soto, C., Bombardi, R. G., Branchizio, A., Kose, N., Matta, P., Sevy, A. M., Sinkovits, R. S., Gilchuk, P., Finn, J. A., & Crowe, J. E. (2019) · Nature · doi:10.1038/s41586-019-0934-8 · Cited by 294 · cited 1×
“Antibody sequence space is estimated to cover up to 1018 unique molecules [111, 115].”
BackgroundKovaltsuk, A., Leem, J., Kelm, S., Snowden, J., Deane, C. M., & Krawczyk, K. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800708 · Cited by 247
Self-citationABodyBuilder: automated antibody structure prediction with data-driven accuracy estimation
Leem, J., Dunbar, J., Georges, G., Shi, J., & Deane, C. M. (2016) · mAbs · doi:10.1080/19420862.2016.1205773 · Cited by 238
RosettaAntibodyDesign (RAbD): a general framework for computational antibody design
Adolf-Bryfogle, J., Kalyuzhniy, O., Kubitz, M., Weitzner, B. D., Hu, X., Adachi, Y., Schief, W. R., & Dunbrack, R. L. (2018) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006112 · Cited by 227
Computational approaches to therapeutic antibody design: established methods and emerging trends
Norman, R. A., Ambrosetti, F., Bonvin, A. M. J. J., Colwell, L. J., Kelm, S., Kumar, S., & Krawczyk, K. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbz095 · Cited by 219 · cited 5×
“Making this paradigm shift in how biological drug discovery and development projects are prosecuted will help realize the vision of Biopharmaceutical Informatics which calls for syncretic use of modern computational and experimental technologies to make biological drug discovery more efficient [7, 99, 145, 146].”
BackgroundMethodInfluentialSelf-citationAntibody structure prediction using interpretable deep learning
Ruffolo, J. A., Sulam, J., & Gray, J. J. (2022) · Patterns · doi:10.1016/j.patter.2021.100406 · Cited by 216 · cited 3×
“Such features are the distances between atoms and the orientation angles (Figure 1F) [19].”
BackgroundMethodInfluentialAbLang: an antibody language model for completing antibody sequences
Olsen, T. H., Moal, I. H., & Deane, C. M. (2022) · Bioinformatics Advances · doi:10.1093/bioadv/vbac046 · Cited by 198
Prihoda, D., Maamary, J., Waight, A., Juan, V., Fayadat-Dilman, L., Svozil, D., & Bitton, D. A. (2022) · mAbs · doi:10.1080/19420862.2021.2020203 · Cited by 190
Improving B-cell epitope prediction and its application to global antibody–antigen docking
Krawczyk, K., Liu, X., Baker, T., Shi, J., & Deane, C. M. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu190 · Cited by 174 · cited 1×
“Their method performs better than previous methods, namely EpiPred [80] and Discotope [82].”
MethodParapred: antibody paratope prediction using convolutional and recurrent neural networks
Liberis, E., Veličković, P., Sormanni, P., Vendruscolo, M., & Liò, P. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty305 · Cited by 165
RosettaAntibody: antibody variable region homology modeling server
Sircar, A., Kim, E. T., & Gray, J. J. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp387 · Cited by 161
Antibody complementarity determining region design using high-capacity machine learning
Liu, G., Zeng, H., Mueller, J., Carter, B., Wang, Z., Schilz, J., Horny, G., Birnbaum, M. E., Ewert, S., & Gifford, D. K. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btz895 · Cited by 157 · cited 2×
“They predicted phage enrichment (better binders) against ranibizumab, bevacizumab, etanercept and trastuzumab based on CDRH3 sequences [47].”
BackgroundMethodABlooper: fast accurate antibody CDR loop structure prediction with accuracy estimation
Abanades, B., Georges, G., Bujotzek, A., & Deane, C. M. (2022) · Bioinformatics · doi:10.1093/bioinformatics/btac016 · Cited by 157
Animal immunization, in vitro display technologies, and machine learning for antibody discovery
Laustsen, A. H., Greiff, V., Karatt-Vellatt, A., Muyldermans, S., & Jenkins, T. P. (2021) · Trends in Biotechnology · doi:10.1016/j.tibtech.2021.03.003 · Cited by 147
Self-citationSecond antibody modeling assessment (AMA-II)
Almagro, J. C., Teplyakov, A., Luo, J., Sweet, R. W., Kodangattil, S., Hernandez‐Guzman, F., & Gilliland, G. L. (2014) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.24567 · Cited by 144
Saka, K., Kakuzaki, T., Metsugi, S., Kashiwagi, D., Yoshida, K., Wada, M., Tsunoda, H., & Teramoto, R. (2021) · Scientific Reports · doi:10.1038/s41598-021-85274-7 · Cited by 144
3D deep convolutional neural networks for amino acid environment similarity analysis
Torng, W., & Altman, R. B. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1702-0 · Cited by 142
Ig-VAE: Generative modeling of protein structure by direct 3D coordinate generation
Eguchi, R. R., Choe, C. A., & Huang, P.-S. (2022) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1010271 · Cited by 141
Ig-VAE: Generative Modeling of Protein Structure by Direct 3D Coordinate Generation
Eguchi, R. R., Choe, C. A., & Huang, P.-S. (2020) · doi:10.1101/2020.08.07.242347 · Cited by 141
Humanization of antibodies using a machine learning approach on large-scale repertoire data
Marks, C., Hummer, A. M., Chin, M., & Deane, C. M. (2021) · Bioinformatics · doi:10.1093/bioinformatics/btab434 · Cited by 124
Aggregation risk prediction for antibodies and its application to biotherapeutic development
Obrezanova, O., Arnell, A., de la Cuesta, R. G., Berthelot, M. E., Gallagher, T. R., Zurdo, J., & Stallwood, Y. (2015) · mAbs · doi:10.1080/19420862.2015.1007828 · Cited by 107 · cited 1×
“models [59] or non-deep learning approaches such as random forests [98] that were reviewed in-depth elsewhere [99].”
BackgroundDLAB-deep learning methods for structure-based virtual screening of antibodies
Schneider, C., Buchanan, A., Taddese, B., & Deane, C. M. (2022) · Bioinformatics · doi:10.1093/bioinformatics/btab660 · Cited by 102 · cited 3×
“DLAB Sorting of protein docking poses 759 Antibody– antigen complexes Convolutional Neural Network n/a PyTorch link [32]”
BackgroundMethodThe H3 loop of antibodies shows unique structural characteristics
Regep, C., Georges, G., Shi, J., Popovic, B., & Deane, C. M. (2017) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.25291 · Cited by 99
Analyzing the ‘Degree of Humanness’ of antibody sequences
Abhinandan, K. R., & Martin, A. C. R. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.02.100 · Cited by 99
In silico proof of principle of machine learning-based antibody design at unconstrained scale
Akbar, R., Robert, P. A., Weber, C. R., Widrich, M., Frank, R., Pavlović, M., Scheffer, L., Chernigovskaya, M., Snapkov, I., Slabodkin, A., et al. (2022) · mAbs · doi:10.1080/19420862.2022.2031482 · Cited by 94
Prediction of site-specific interactions in antibody–antigen complexes: the proABC method and server
Olimpieri, P. P., Chailyan, A., Tramontano, A., & Marcatili, P. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt369 · Cited by 90 · cited 1×
“Methods used to analyze antibody–antigen interactions were previously categorized into paratope [43, 77, 78], epitope [79–82], or docking [83–85] reviewed previously [7].”
MethodKrawczyk, K., Baker, T., Shi, J., & Deane, C. M. (2013) · Protein Engineering Design and Selection · doi:10.1093/protein/gzt043 · Cited by 87 · cited 1×
“Methods used to analyze antibody–antigen interactions were previously categorized into paratope [43, 77, 78], epitope [79–82], or docking [83–85] reviewed previously [7].”
MethodSelf-citationAbDb: antibody structure database-a database of PDB-derived antibody structures
Ferdous, S., & Martin, A. C. R. (2018) · Database · doi:10.1093/database/bay040 · Cited by 87
Kumar, S., Singh, S. K., Wang, X., Rup, B., & Gill, D. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0414-9 · Cited by 85
Self-citationCurrent structure predictors are not learning the physics of protein folding
Outeiral, C., Nissley, D. A., & Deane, C. M. (2022) · Bioinformatics · doi:10.1093/bioinformatics/btab881 · Cited by 82
Li, T., Pantazes, R. J., & Maranas, C. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105954 · Cited by 79
Jain, T., Boland, T., Lilov, A., Burnina, I., Brown, M., Xu, Y., & Vásquez, M. (2017) · Bioinformatics · doi:10.1093/bioinformatics/btx519 · Cited by 61
Humanization of antibodies using a statistical inference approach
Clavero-Álvarez, A., Di Mambro, T., Perez-Gaviro, S., Magnani, M., & Bruscolini, P. (2018) · Scientific Reports · doi:10.1038/s41598-018-32986-y · Cited by 47 · cited 1×
“To quantify possible positional correlations, an multivariate gaussian (MG) statistical score was developed based on the OAS data [105].”
MethodStructurally mapping antibody repertoires
Krawczyk, K., Kelm, S., Kovaltsuk, A., Galson, J. D., Kelly, D., Trück, J., Regep, C., Leem, J., Wong, W. K., Nowak, J., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01698 · Cited by 42 · cited 2×
“The predictions are approaching sufficient levels to be reliably used as substitutes for crystal structures, specifically providing models at speed and scale [76] necessary to tackle the antibody-binding problem for the ultimate prize of virtual antibody screening.”
BackgroundLooking for therapeutic antibodies in next generation sequencing repositories
Krawczyk, K., Raybould, M., Kovaltsuk, A., & Deane, C. M. (2019) · doi:10.1101/572958 · Cited by 29
Self-citationAbDiver-a tool to explore the natural antibody landscape to aid therapeutic design
Młokosiewicz, J., Deszyński, P., Wilman, W., Jaszczyszyn, I., Ganesan, R., Kovaltsuk, A., Leem, J., Galson, J. D., & Krawczyk, K. (2022) · Bioinformatics · doi:10.1093/bioinformatics/btac151 · Cited by 19
Self-citation
Research works printed but not linked: 83
- Krawczyk, 2021, Data mining patented antibody sequences, MAbs, 13, 1892366, 10.1080/19420862.2021.1892366 · DOI
- Kaplon, 2022, Antibodies to watch in 2022, MAbs, 14, 2014296, 10.1080/19420862.2021.2014296 · DOI · Paper page
- Kaplon, 2021, Antibodies to watch in 2021, MAbs, 13, 1860476, 10.1080/19420862.2020.1860476 · DOI · Paper page
- Arslan, 2021, Antibody-mediated drug delivery, Int J Pharm, 596, 120268, 10.1016/j.ijpharm.2021.120268 · DOI
- Ferrara, 2022, A pandemic-enabled comparison of discovery platforms demonstrates a naïve antibody library can match the best immune-sourced antibodies, Nat Commun, 13, 462, 10.1038/s41467-021-27799-z · DOI
- Breden, 2020, 486 iReceptor plus: a data integration platform to share, compare and analyze adaptive immune receptor repertoire (AIRR-seq) data from antibody/B- and T-cell repertoires, J Immunother Cancer, 8, A522
- Graves, 2020, A review of deep learning methods for antibodies, Antibodies (Basel), 9, 12, 10.3390/antib9020012 · DOI · Paper page
- Pertseva, 2021, Applications of machine and deep learning in adaptive immunity, Annu Rev Chem Biomol Eng, 12, 39, 10.1146/annurev-chembioeng-101420-125021 · DOI
- Robert, 2021, One billion synthetic 3D-antibody-antigen complexes enable unconstrained machine-learning formalized investigation of antibody specificity prediction, 10.1101/2021.07.06.451258 · DOI
- Lefranc, 2003, IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains, Dev Comp Immunol, 27, 55, 10.1016/S0145-305X(02)00039-3 · DOI · Paper page
- Abhinandan, 2008, Analysis and improvements to Kabat and structurally correct numbering of antibody variable domains, Mol Immunol, 45, 3832, 10.1016/j.molimm.2008.05.022 · DOI · Paper page
- Cohen, 2021, NanoNet: rapid end-to-end nanobody modeling by deep learning at sub angstrom resolution, 10.1101/2021.08.03.454917 · DOI
- Pittala, 2020, Learning context-aware structural representations to predict antigen and antibody binding interfaces, Bioinformatics, 36, 3996, 10.1093/bioinformatics/btaa263 · DOI · Paper page
- Chakrabarty, 2016, NAPS: network analysis of protein structures, Nucleic Acids Res, 44, W375, 10.1093/nar/gkw383 · DOI · Paper page
- Brinda, 2005, A network representation of protein structures: implications for protein stability, Biophys J, 89, 4159, 10.1529/biophysj.105.064485 · DOI · Paper page
- Leem, 2021, Deciphering the language of antibodies using self-supervised learning, 10.1101/2021.11.10.468064 · doi:10.1101/2021.11.10.468064
- Proteins, 74
- Cho, 2014, Learning phrase representations using RNN encoder-decoder for statistical machine translation, 10.3115/v1/D14-1179 · DOI · Paper page
- Wollacott, 2019, Quantifying the nativeness of antibody sequences using long short-term memory networks, Protein Eng Des Sel, 32, 347, 10.1093/protein/gzz031 · DOI
- Ripoll, 2021, Using the antibody-antigen binding interface to train image-based deep neural networks for antibody-epitope classification, PLoS Comput Biol, 17, e1008864, 10.1371/journal.pcbi.1008864 · DOI
- Amimeur, 2020, Designing feature-controlled humanoid antibody discovery libraries using generative adversarial networks, 10.1101/2020.04.12.024844 · DOI · Paper page
- Samek, 2019, Explainable AI: Interpreting, Explaining and Visualizing Deep Learning, 5, 10.1007/978-3-030-28954-6_1 · DOI · Paper page
- Vaswani, 2017, Attention is all you need, Adv Neural Inf Process Syst, 30
- Ott, 2019, Fairseq: a fast, extensible toolkit for sequence Modeling, 10.18653/v1/N19-4009 · DOI · Paper page
- Silva, 2022, epitope3D: a machine learning method for conformational B-cell epitope prediction, Brief Bioinform, 23, bbab423, 10.1093/bib/bbab423 · DOI · Paper page
- Myung, 2020, mmCSM-AB: guiding rational antibody engineering through multiple point mutations, Nucleic Acids Res, 48, W125, 10.1093/nar/gkaa389 · DOI
- He, 2016, Proceedings of the IEEE conference on computer vision and pattern recognition, 770
- Ostrovsky-Berman, 2021, Immune2vec: embedding B/T cell receptor sequences in ℝN using natural language processing, Front Immunol, 12, 680687, 10.3389/fimmu.2021.680687 · DOI
- Asgari, 2015, Continuous distributed representation of biological sequences for deep proteomics and genomics, PLoS One, 10, e0141287, 10.1371/journal.pone.0141287 · DOI · Paper page
- Friedensohn, 2020, Convergent selection in antibody repertoires is revealed by deep learning, 10.1101/2020.02.25.965673 · DOI
- Shuai, 2021, Generative language Modeling for antibody design, 10.1101/2021.12.13.472419 · DOI
- Khan, 2022, AntBO: towards real-world automated antibody design with combinatorial Bayesian optimisation, 10.2139/ssrn.4115860 · DOI
- Akbar, 2021, A compact vocabulary of paratope-epitope interactions enables predictability of antibody-antigen binding, Cell Rep, 34, 108856, 10.1016/j.celrep.2021.108856 · DOI · Paper page
- Kovaltsuk, 2017, How B-cell receptor repertoire sequencing can be enriched with structural antibody data, Front Immunol, 8, 1753, 10.3389/fimmu.2017.01753 · DOI · Paper page
- Jones, 2015, MetaPSICOV: combining coevolution methods for accurate prediction of contacts and long range hydrogen bonding in proteins, Bioinformatics, 31, 999, 10.1093/bioinformatics/btu791 · DOI · Paper page
- Yamashita, 2014, Kotai antibody builder: automated high-resolution structural modeling of antibodies, Bioinformatics, 30, 3279, 10.1093/bioinformatics/btu510 · DOI · Paper page
- Jeliazkov, 2021, Robustification of RosettaAntibody and Rosetta SnugDock, PLoS One, 16, e0234282, 10.1371/journal.pone.0234282 · DOI · Paper page
- Marcatili, 2008, PIGS: automatic prediction of antibody structures, Bioinformatics, 24, 1953, 10.1093/bioinformatics/btn341 · DOI · Paper page
- Källberg, 2012, Template-based protein structure modeling using the RaptorX web server, Nat Protoc, 7, 1511, 10.1038/nprot.2012.085 · DOI · Paper page
- Weitzner, 2014, Blind prediction performance of RosettaAntibody 3.0: grafting, relaxation, kinematic loop modeling, and full CDR optimization, Proteins, 82, 1611, 10.1002/prot.24534 · DOI · Paper page
- Adolf-Bryfogle, 2015, PyIgClassify: a database of antibody CDR structural classifications, Nucleic Acids Res, 43, D432, 10.1093/nar/gku1106 · DOI · Paper page
- Du, 2021, The trRosetta server for fast and accurate protein structure prediction, Nat Protoc, 16, 5634, 10.1038/s41596-021-00628-9 · DOI · Paper page
- Jespersen, 2017, BepiPred-2.0: improving sequence-based B-cell epitope prediction using conformational epitopes, Nucleic Acids Res, 45, W24, 10.1093/nar/gkx346 · DOI · Paper page
- Sweredoski, 2008, PEPITO: improved discontinuous B-cell epitope prediction using multiple distance thresholds and half sphere exposure, Bioinformatics, 24, 1459, 10.1093/bioinformatics/btn199 · DOI · Paper page
- Sircar, 2010, SnugDock: paratope structural optimization during antibody-antigen docking compensates for errors in antibody homology models, PLoS Comput Biol, 6, e1000644, 10.1371/journal.pcbi.1000644 · DOI · Paper page
- Guest JD, Vreven T, Zhou J, Moal I, Jeliazkov JR, Gray JJ, Weng Z, Pierce BG, 2021, An expanded benchmark for antibody-antigen docking and affinity prediction reveals insights into antibody recognition determinants, 606
- Ambrosetti, 2020, Modeling antibody-antigen complexes by information-driven docking, Structure, 28, 119, 10.1016/j.str.2019.10.011 · DOI · Paper page
- Sharma, 2014, In silico selection of therapeutic antibodies for development: viscosity, clearance, and chemical stability, Proc Natl Acad Sci U S A, 111, 18601, 10.1073/pnas.1421779112 · DOI · Paper page
- Jurtz, 2017, NetMHCpan-4.0: improved peptide-MHC class I interaction predictions integrating eluted ligand and peptide binding affinity data, J Immunol, 199, 3360, 10.4049/jimmunol.1700893 · DOI · Paper page
- Maia, 2020, Structure-based virtual screening: from classical to artificial intelligence, Front Chem, 8, 343, 10.3389/fchem.2020.00343 · DOI · Paper page
- Geng, 2020, iScore: a novel graph kernel-based function for scoring protein-protein docking models, Bioinformatics, 36, 112, 10.1093/bioinformatics/btz496 · DOI · Paper page
- Renaud, 2021, DeepRank: a deep learning framework for data mining 3D protein-protein interfaces, Nat Commun, 12, 7068, 10.1038/s41467-021-27396-0 · DOI · Paper page
- Wang, 2020, Protein docking model evaluation by 3D deep convolutional neural networks, Bioinformatics, 36, 2113, 10.1093/bioinformatics/btz870 · DOI · Paper page
- Kilambi, 2017, Structure-based cross-docking analysis of antibody–antigen interactions, Sci Rep, 7, 1, 10.1038/s41598-017-08414-y · DOI
- Hummer, 2022, Advances in computational structure-based antibody design, Curr Opin Struct Biol, 74, 102379, 10.1016/j.sbi.2022.102379 · DOI · Paper page
- Khetan, 2022, Current advances in biopharmaceutical informatics: guidelines, impact and challenges in the computational developability assessment of antibody therapeutics, MAbs, 14, 2020082, 10.1080/19420862.2021.2020082 · DOI
- Kim, 2012, Humanization by CDR grafting and specificity-determining residue grafting, Methods Mol Biol, 907, 237, 10.1007/978-1-61779-974-7_13 · DOI
- Gao, 2013, Monoclonal antibody humanness score and its applications, BMC Biotechnol, 13, 55, 10.1186/1472-6750-13-55 · DOI · Paper page
- Schmitz, 2020, Human-likeness of antibody biologics determined by back-translation and comparison with large antibody variable gene repertoires, MAbs, 12, 1758291, 10.1080/19420862.2020.1758291 · DOI
- Sheng, 2017, Gene-specific substitution profiles describe the types and frequencies of amino acid changes during antibody somatic Hypermutation, Front Immunol, 8, 537, 10.3389/fimmu.2017.00537 · DOI · Paper page
- Fathallah, 2015, The effect of small oligomeric protein aggregates on the immunogenicity of intravenous and subcutaneous administered antibodies, J Pharm Sci, 104, 3691, 10.1002/jps.24592 · DOI
- Lazar, 2007, A molecular immunology approach to antibody humanization and functional optimization, Mol Immunol, 44, 1986, 10.1016/j.molimm.2006.09.029 · DOI
- Boeckmann, 2003, The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003, Nucleic Acids Res, 31, 365, 10.1093/nar/gkg095 · DOI · Paper page
- Alfaleh, 2020, Phage display derived monoclonal antibodies: from bench to bedside, Front Immunol, 11, 1986, 10.3389/fimmu.2020.01986 · DOI · Paper page
- Rees, 2014, Antibody structure prediction and development of humanization strategies, The Antibody Molecule, 260
- Galson, 2020, Deep sequencing of B cell receptor repertoires from COVID-19 patients reveals strong convergent immune signatures, Front Immunol, 11, 605170, 10.3389/fimmu.2020.605170 · DOI · Paper page
- Radford, 2019, Language models are unsupervised multitask learners, OpenAI blog, 1, 9
- Akbar, 2022, Progress and challenges for the machine learning-based design of fit-for-purpose monoclonal antibodies, MAbs, 14, 2008790, 10.1080/19420862.2021.2008790 · DOI · Paper page
- Brooks, 1983, CHARMM: a program for macromolecular energy, minimization, and dynamics calculations, J Comput Chem, 4, 187, 10.1002/jcc.540040211 · DOI · Paper page
- Richardson, 2021, A computational method for immune repertoire mining that identifies novel binders from different clonotypes, demonstrated by identifying anti-pertussis toxoid antibodies, MAbs, 13, 1869406, 10.1080/19420862.2020.1869406 · DOI · Paper page
- Crowe, 2022, Human antibodies for viral infections, Annu Rev Immunol, 40, 349, 10.1146/annurev-immunol-042718-041309 · DOI
- Christley, 2020, The ADC API: a web API for the programmatic query of the AIRR data commons, Front Big Data, 3, 22, 10.3389/fdata.2020.00022 · DOI
- Deszyński, 2022, INDI—integrated nanobody database for immunoinformatics, Nucleic Acids Res, 50, D1273, 10.1093/nar/gkab1021 · DOI
- Corrie, 2018, iReceptor: a platform for querying and analyzing antibody/B-cell and T-cell receptor repertoire data across federated repositories, Immunol Rev, 284, 24, 10.1111/imr.12666 · DOI · Paper page
- Lima, 2020, The ABCD database: a repository for chemically defined antibodies, Nucleic Acids Res, 48, D261, 10.1093/nar/gkz714 · DOI
- Pavlović, 2021, The immuneML ecosystem for machine learning analysis of adaptive immune receptor repertoires, Nat Mach Intell, 3, 936, 10.1038/s42256-021-00413-z · DOI
- Jones, 2021, ClonoMatch: a tool for identifying homologous immunoglobulin and T cell receptor sequences in large databases, Bioinformatics, 36, 5695, 10.1093/bioinformatics/btaa1028 · DOI
- Sang, 2021, Llamanade: an open-source computational pipeline for robust nanobody humanization, Structure, 30, 418, 10.1016/j.str.2021.11.006 · DOI
- Kovaltsuk, 2020, Structural diversity of B-cell receptor repertoires along the B-cell differentiation axis in humans and mice, PLoS Comput Biol, 16, e1007636, 10.1371/journal.pcbi.1007636 · DOI · Paper page
- Raybould, 2021, Public baseline and shared response structures support the theory of antibody repertoire functional commonality, PLoS Comput Biol, 17, e1008781, 10.1371/journal.pcbi.1008781 · DOI
- Robinson, 2021, Epitope profiling using computational structural modelling demonstrated on coronavirus-binding antibodies, PLoS Comput Biol, 17, e1009675, 10.1371/journal.pcbi.1009675 · DOI · Paper page
- Kumar, 2018, Biopharmaceutical informatics: supporting biologic drug development via molecular modelling and informatics, J Pharm Pharmacol, 70, 595, 10.1111/jphp.12700 · DOI
- Kumar, 2015, Developability of Biotherapeutics: Computational Approaches, 10.1201/b19023 · doi:10.1201/b19023
Cited by
Bashour, H., Smorodina, E., Pariset, M., Zhong, J., Akbar, R., Chernigovskaya, M., Lê Quý, K., Snapkow, I., Rawat, P., Krawczyk, K., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-06561-3 · Cited by 32
Self-citationKończak, J., Janusz, B., Młokosiewicz, J., Satława, T., Wróbel, S., Dudzic, P., & Krawczyk, K. (2023) · ImmunoInformatics · doi:10.1016/j.immuno.2023.100028 · Cited by 5
Self-citationChomicz, D., Dudzic, P., Wrobel, S., Gawłowski, T., Demharter, S., Spreafico, R., Minoux, H., Phillips, A., & Krawczyk, K. (2025) · doi:10.1101/2025.10.17.683056 · Cited by 4
“Antibodies have different molecular contact preferences than ‘general’ proteins (Krawczyk et al. 2013), requiring the development of a specific set of binding prediction tools (Norman et al. 2020; Wilman et al. 2022).”
Self-citationChomicz, D., Dudzic, P., Wrobel, S., Gawlowski, T., Demharter, S., Spreafico, R., Minoux, H., Phillips, A., & Krawczyk, K. (2026) · mAbs · doi:10.1080/19420862.2026.2630438 · Cited by 4
Self-citation
Metadata
- Authors
- Wilman, W., Wróbel, S., Bielska, W., Deszynski, P., Dudzic, P., Jaszczyszyn, I., Kaniewski, J., Młokosiewicz, J., Rouyan, A., Satława, T., Kumar, S., Greiff, V., & Krawczyk, K.
- Venue
- Briefings in Bioinformatics
- Publisher
- Oxford University Press (OUP)
- Published
- 2022-07-14
- Volume
- 23
- Issue
- 4
- ISSN
- 1467-5463 (ISSN-L)
- 1477-4054
- OpenAlex
- W4285386587
- Cited by
- 79
- References
- 58
- FWCI
- 9.01
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Funders
- European Regional Development Fund (2014-2020 POIR.01.01.01-00-0962/21)
- Helmsley Charitable Trust (#2019PG-T1D011)
- UiO:LifeSciences Convergence Environment Immunolingo (#825821)
- Research Council of Norway FRIPRO project (#300740)
- Research Council of Norway (#311341)
- Norwegian Cancer Society (#215817)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.